First-in-man Trial of NNC0142-0002 in Patients With Rheumatoid Arthritis

NCT00927927 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

65

Enrollment

INDUSTRY

Sponsor class

Conditions

Inflammation
Rheumatoid Arthritis

Interventions

DRUG: NNC0142-0002
DRUG: NNC0142-0002
DRUG: NNC0142-0002
DRUG: NNC0142-0002
DRUG: NNC0142-0002
DRUG: NNC0142-0002
DRUG: NNC0142-0002
DRUG: NNC0142-0002
DRUG: placebo
DRUG: NNC0142-0002
DRUG: NNC0142-0002
DRUG: NNC0142-0002
DRUG: NNC0142-0002
DRUG: NNC0142-0002
DRUG: placebo

Sponsor

Janssen Research & Development, LLC